Location History:
- Carquefou, FR (2021)
- Nantes, FR (2021 - 2022)
Company Filing History:
3 out of 1,744 
2 out of 141 
2 out of 23 
Years Active: 2021-2022
Title: The Innovative Mind of Magali Giral: A Look into Her Contributions to Science
Introduction
Magali Giral, a prominent inventor based in Nantes, France, has made significant strides in the field of immunology through her innovative work and research. With three patents to her name, Magali has demonstrated a commitment to advancing medical science, particularly in the area of immunogenicity and operational tolerance.
Latest Patents
Magali's latest patents include groundbreaking methods and compositions. One such patent is aimed at discriminating between operationally tolerant (TOL) subjects and non-operationally tolerant (STA) subjects. This method is vital in understanding patient responses in transplantation and immunotherapy. Another noteworthy patent describes a composition composed of polyclonal antibodies that target human cells. This composition is devoid of specific antigenic determinants, such as N-glycol-neuraminic acid and α-1,3-galactose, making it potentially suitable for therapeutic use as a medicament.
Career Highlights
Throughout her career, Magali has worked with notable institutions like Inserm (Institut National de la Santé et de la Recherche Médicale) and Université de Nantes. Her work at these institutions has not only contributed to her knowledge and expertise but also addressed key challenges in medical science.
Collaborations
Collaboration is a cornerstone of innovation, and Magali has had the privilege to work alongside esteemed colleagues, including Sophie Brouard and Richard Danger. Their collective efforts have fostered a greater understanding of immune responses and have accelerated the pace of discovery in their field.
Conclusion
Magali Giral stands out as a remarkable inventor, whose contributions have the potential to influence the medical landscape significantly. Her ongoing research and inventions demonstrate her dedication to improving patient outcomes and advancing science. As she continues to innovate, there is no doubt that her work will leave a lasting impact in the field of immunology.